Clinical Trial Update: A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

View source ↗

Summary

A clinical trial update shows a South Korea study of lanadelumab (Takhzyro) for hereditary angioedema in teenagers and adults is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Takhzyro (lanadelumab)

Snippet

Sponsor: Takeda | Conditions: Hereditary Angioedema (HAE) | Status: NOT_YET_RECRUITING